Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04491084
Status:
TERMINATED
Last Update Posted:
2024-02-28
First Post:
2020-07-21
Brief Title:
FLT3 Ligand CD40 Agonist Antibody and Stereotactic Radiotherapy
Sponsor:
Albert Einstein College of Medicine
Organization:
Albert Einstein College of Medicine
Organization Data
Organization:
Albert Einstein College of Medicine
Class:
OTHER
Study ID:
2020-11868
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Albert Einstein College of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celldex Therapeutics | INDUSTRY |